Clinical Trials Logo

Clinical Trial Summary

Nowadays, general anaesthesia is carried under "balanced anesthesia technique" in which many anesthetic adjuvants are used simultaneously, including opioid analgesics in order to reduce the amount of inhalation agents. The most popular adjuvants used are remifentanil, which is an opioid analgesic, and dexmedetomidine. Both of these agents are short acting, can be infused with targeted concentrations, excreted shortly from the body with stable hemodynamics.

Remifentanil, when infused for more than 2 hours, causes hyperalgesia to increase the amount of pain postoperatively as well as the amount of opioid analgesics. However, dexmedetomidine does not cause hyperalgesia and is known to have an opioid -sparing effect. In our center.

In this study, we aim to compare the effects of remifentanil and dexmedetomidine on postoperative pain in patients undergoing Nuss procedure, which is a very painful operation on the chest wall.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04073758
Study type Interventional
Source Seoul St. Mary's Hospital
Contact
Status Enrolling by invitation
Phase N/A
Start date September 2, 2019
Completion date February 28, 2021

See also
  Status Clinical Trial Phase
Completed NCT00252252 - AutoVPAP Versus VPAP; Assessment of Sleep and Ventilation Phase 1
Recruiting NCT03171012 - Addition of Proprioceptive Neuromuscular Facilitation to Cardio Respiratory Training Post Stroke N/A
Completed NCT01644162 - Ventilator Monitoring in Early Exacerbation Detection N/A
Completed NCT04279886 - Three-dimensional Scanning of the Chest: a Comparison Between Three Different Imaging Modalities N/A
Withdrawn NCT01174316 - Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Acute Exacerbation of Respiratory Failure N/A
Completed NCT00901485 - Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Newly Diagnosed Patients N/A